GenoTher Summit 2026
- annechalumeau
- 8 hours ago
- 1 min read
The ART-TG is part of the Genomics and Genome Editing Quality Control platform of the biocluster Genother that offers a range of analytical tests in vitro and in vivo on Advanced Therapy Medicinal Products (ATMPs) using CRISPR tools or lentiviral vectors. The platform aims to bring more precise and safer therapies to the clinic, ensuring regulatory compliance with the highest quality standards.
The platform is powered by 3 Inserm laboratories: Anne Galy's ART-TG, Annarita Miccio's laboratory in U1163 at Institute Imagine and Mario Amendola's laboratory in U951 at Genethon.
Prof. Anne Galy will present the platform during the GenoTher Summit 2026 on Wednesday, June 17th afternoon.
Come and meet us at the GenoTher Summit 2026 !
Program at a glance : here
Comments